{{Rsnum
|rsid=6449213
|Gene=SLC2A9
|Chromosome=4
|position=9992591
|Orientation=plus
|GMAF=0.1299
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC2A9
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 34.5 | 63.7
| HCB | 0.0 | 3.6 | 96.4
| JPT | 0.0 | 1.8 | 98.2
| YRI | 1.4 | 22.4 | 76.2
| ASW | 0.0 | 29.8 | 70.2
| CHB | 0.0 | 3.6 | 96.4
| CHD | 0.0 | 9.2 | 90.8
| GIH | 0.0 | 29.7 | 70.3
| LWK | 0.0 | 20.9 | 79.1
| MEX | 5.2 | 29.3 | 65.5
| MKK | 1.3 | 30.1 | 68.6
| TSI | 2.9 | 27.5 | 69.6
| HapMapRevision=28
}}
This is basically a surrogate for [[rs7442295]], and thus associated with higher serum urate levels.

{{omim
|desc=HYPOURICEMIA, RENAL, 2; RHUC2
|id=612076
|rsnum=6449213
}}

{{omim
|id=606142
|desc=SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
|rsnum=6449213
}}

{{PMID Auto
|PMID=20589538
|Title=Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson's Disease
}}

{{omim
|id=606142
|rsnum=6449213
|variant=0002
}}

{{PMID Auto
|PMID=18179892
|Title=Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
|OA=1
}}

{{PMID Auto
|PMID=18398472
|Title=Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
|OA=1
}}

{{PMID Auto
|PMID=18487473
|Title=Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.
|OA=1
}}

{{PMID Auto
|PMID=18606621
|Title=SLC2A9--a fructose transporter identified as a novel uric acid transporter.
|OA=1
}}

{{PMID Auto
|PMID=18834626
|Title=Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=19260141
|Title=Genome-wide association study of biochemical traits in Korcula Island, Croatia.
|OA=1
}}

{{PMID Auto
|PMID=20053405
|Title=Sex and age interaction with genetic association of atherogenic uric acid concentrations.
|OA=1
}}

{{PMID Auto
|PMID=20162742
|Title=Predictive value of 8 genetic loci for serum uric acid concentration.
|OA=1
}}

{{PMID Auto
|PMID=20162743
|Title=Common variants in SLC17A3 gene affect intra-personal variation in serum uric acid levels in longitudinal time series.
|OA=1
}}

{{PMID Auto
|PMID=20162744
|Title=Interactions between genetic variants in glucose transporter type 9 (SLC2A9) and dietary habits in serum uric acid regulation.
|OA=1
}}

{{PMID Auto
|PMID=20162745
|Title=Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients.
|OA=1
}}

{{PMID Auto
|PMID=20348110
|Title=Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.
|OA=1
}}

{{PMID Auto
|PMID=21294900
|Title=A genome-wide association study of serum uric acid in African Americans.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23703922
  |Trait=Uric acid levels
  |Title=A genome wide association study of plasma uric acid levels in obese cases and never-overweight controls.
  |RiskAllele=
  |Pval=3E-12
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}